BILLS-119hr679ih.pdf - Research Document Archive

Loading OCR text...

DATE (4)

2025 23:09 Feb 19 JANUARY 23 January 2023

EVENT (2)

SESSION H. R. 679 MIFEPRISTONE

GPE (7)

Louisiana Oklahoma Texas Illinois Arizona the United States of America Florida

LOC (1)

IH

ORG (18)

Congress the Food and Drug Administration House of Representa- the Food and Drug Administration the Federal Food, Drug Food, Drug FEENSTRA Senate Energy and Commerce THE HOUSE OF REPRESENTATIVES the Department of 6 Health and Human Services NULLIFICATION.—The Health and Human Services Food and Drug Administration Federal U.S.C. REMS

PERSON (13)

BAIRD BOST WEBSTER BIGGS YAKYM BABIN HERN PALMER HARSHBARGER WEBER MILLER HIGGINS MOOLENAAR

Topic Classifications

congressional legislation 94.2%

government oversight 76.6%

public health 56.9%

Extracted Keywords

mifepristone modifications food drug drug administration mitigation strategy drug evaluation substantially similar food abortion cosmetic act drug cosmetic federal food cosmetic

Forensic Analysis

PDF Metadata

Creator: U.S. Gov. Printing Office -- G.S.D.D.
ModDate: D:20250221113735Z
Producer: Acrobat Distiller 24.0 (Windows); modified using iText® Core 7.2.3 (production version) ©2000-2022 iText Group NV, Government Publishing Office
CreationDate: D:20250221052804-05'00'

Sentiment

Polarity

Neutral

-0.036

Subjectivity

26%

Objective

No crisis correlations found for this document.

The ML pipeline may still be processing.